JANX

NASDAQ · Equity

Janux Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
14.590000
Fair value
27.172436
Expectation
Negative 44.04%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
14.59
12-Week Change
7.44%
Trend Signal
Inactive
Expectation
Negative 44.04%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-40.85
Market Dynamics
0.54

Over the latest 12 completed weeks ending 2026-05-29, JANX rose 7.44%, moving from 13.58 to 14.59. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -40.85 and has improved across the 12-week window. Market Dynamics is 0.54 on the latest week. Expectation is negative at 44.04%.